Intelence (etravirine; TMC125) developed by Tibotec Pharmaceuticals. Marketed in the U.S. by Tibotec Therapeutics, a division of Ortho Biotech Products. | Intelence (etravirine) Tablets, Tibotec Inc., Approval
^ FDA's latest approval appears at the bottom of this list. ^